Answers are grounded in this paper and cite their sources.
Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.
No takes yet. Share an insight, caveat, or question.
Luykx et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: